A recently reported quantitative magnetic resonance imaging (MRI) method denoted OxFlow has been shown to be able to quantify whole-brain cerebral metabolic rate of oxygen (CMRO 2 ) by simultaneously measuring oxygen saturation (S v O 2 ) in the superior sagittal sinus and cerebral blood flow (CBF) in the arteries feeding the brain in 30 seconds, which is adequate for measurement at baseline but not necessarily in response to neuronal activation. Here, we present an accelerated version of the method (referred to as F-OxFlow) that quantifies CMRO 2 in 8 seconds scan time under full retention of the parent method's capabilities and compared it with its predecessor at baseline in 10 healthy subjects. Results indicate excellent agreement between both sequences, with mean bias of 2.2% (P = 0.18, two-tailed t-test), 3.4% (P = 0.08, two-tailed t-test), and 2.0% (P = 0.56, two-tailed t-test) for S v O 2 , CBF, and CMRO 2 , respectively. F-OxFlow's potential to monitor dynamic changes in S v O 2 , CBF, and CMRO 2 is illustrated in a paradigm of volitional apnea applied to five of the study subjects. The sequence captured an average increase in S v O 2 , CBF, and CMRO 2 of 10.1 ± 2.5%, 43.2 ± 9.2%, and 7.1 ± 2.2%, respectively, in good agreement with literature values. The method may therefore be suited for monitoring alterations in CBF and S v O 2 in response to neurovascular stimuli.
INTRODUCTION
The brain relies almost entirely on aerobic metabolism. Alterations in cerebral metabolic rate of oxygen (CMRO 2 ) may represent an important index of metabolic dysregulation in common brain diseases including Alzheimer's, Parkinson's, multiple sclerosis, and Huntington's disease. [1] [2] [3] [4] So far, most studies involving measurement of CMRO 2 have relied on positron emission tomography. 5, 6 Another method for CMRO 2 quantification is based on measurement of brain oxygen saturation (S v O 2 ) via jugular vein catheterization, 7 while the cerebral flow is measured by either optical coherence tomography or Doppler ultrasound.
In recent years, some noninvasive magnetic resonance imaging (MRI) approaches have emerged for measuring CMRO 2 based on quantifying S v O 2 via measurement of blood transverse relaxation time (T 2 ). [8] [9] [10] The most commonly used approach, T 2 -relaxation under spin tagging (TRUST), is combined with phase-contrast MRI to quantify the total cerebral blood flow (CBF). TRUST in its various embodiments 8, [11] [12] [13] [14] has been found to be reliable and reproducible and has showed its usefulness in a number of translational patient studies including multiple sclerosis. 1 However, its relatively long acquisition time of about 4 minutes limits its utility for assessing dynamic CMRO 2 changes in response to physiologic challenges.
In recent work by some of the authors, global CMRO 2 was measured at 30-second temporal resolution, 15 here referred to as OxFlow (as the method quantifies both CBF and oxygen saturation in a single step). OxFlow was designed to quantify superior sagittal sinus (SSS) S v O 2 by means of MR susceptometry-based oximetry 16, 17 and simultaneously CBF in the major arteries feeding the brain, by means of four interleaved gradient-recalled echoes alternating between brain and neck locations, yielding S v O 2 and CBF.
The 30-second temporal resolution OxFlow was implemented to detect changes in CMRO 2 in response to a hypercapnic challenge. 18 Measurement of cerebrovascular reactivity can be achieved by means of volitional apnea in the form of a breathhold test (BHT). 19 Previous reports showed that BHT is useful to obtain functional information in patients with carotid occlusive disease. 20, 21 It also simulates the chronic intermittent hypoxia that occurs in obstructive sleep apnea, and thus the BHT may provide a particularly relevant metric of cerebrovascular reactivity in these patients. 22 However, OxFlow's acquisition time of 30 seconds limits the technique's use for obtaining time-resolved CMRO 2 measurements in response to the BHT. More recently, a very fast (3-second temporal resolution) MRI method for whole-brain CMRO 2 measurement that quantifies both S v O 2 and CBF in the SSS was introduced. 23 However, the method requires an initial calibration step to quantify the SSS blood flow (SSS-BF) to total CBF (tCBF) ratio, allowing subsequent derivation of tCBF from continuously-measured SSS-BF.
There are several motivations for measuring neurometabolic parameters with high temporal resolution. Among these are blood oxygen level-dependent-based methods to ascertain whether the gas mixture breathing stimuli (hypercapnia and hyperoxia) 24 or breath-hold 25 are isometabolic and over what time frame. This is achievable by applying the technique via global stimuli. Apnea, as in obstructive sleep apnea is another important area of investigation. Again, this is associated with global variations in oxygen metabolism and is therefore assessable via global CMRO 2 measurement.
The purpose of this work was to design and implement a substantially enhanced OxFlow sequence (henceforth referred to as fast OxFlow or F-OxFlow) that quantifies CMRO 2 with fourfold increased temporal resolution (8 seconds) compared with the original implementation, 15 and to evaluate its performance at baseline and during a volitional apnea paradigm.
MATERIALS AND METHODS

Principle of Magnetic Resonance Imaging-Based Cerebral Metabolic Rate of Oxygen Quantification
Cerebral metabolic rate of oxygen is quantified by combining venous and arterial oxygenation and CBF using Fick's law: 26
where C a is the blood's oxygen carrying capacity expressed in μmol O 2 per 100 mL blood. C a was calculated for each subject based on their hemoglobin level assuming 1.39 mL of O 2 per gram of hemoglobin as the O 2 carrying capacity of hemoglobin. 27 Global CBF represents the total in-flow through the feeding left and right internal carotid and vertebral arteries. S a O 2 and S v O 2 are the arterial and SSS venous oxygen saturation, respectively. For healthy subjects S a O 2 was assumed to be 98% at baseline but during the volitional apneic paradigm S a O 2 was monitored with a digital pulse oximeter clipped to the right middle finger.
The MR susceptometry-based oximetry was used to quantify S v O 2 in the SSS instead of internal jugular veins to avoid severe static field inhomogeneity due to the proximity of oral cavity and trachea. Previous studies 8, 28 have shown good agreement between the S v O 2 measured in the SSS and internal jugular veins S v O 2 .
Susceptometry-based oximetry relies on measurement of the magnetic susceptibility difference Δχ = χ do Hct (1 − S v O 2 /100) between the intravascular blood and surrounding tissue, with χ do = 4π (0.27) p.p.m. representing the susceptibility difference (in SI units) between fully deoxygenated and fully oxygenated blood, 29 and Hct the hematocrit. By modeling the vessel as a long paramagnetic cylinder, 16, 17 the induced magnetic field (ΔB) relative to the surrounding tissue can be approximated as:
where θ is the vessel tilt angle relative to the main field B o . Cerebral blood flow was quantified using a nongated phase-contrast technique as described in Jain et al. 15 Pulse Sequence for Cerebral Metabolic Rate of Oxygen Quantification
The parent OxFlow pulse sequence 15 was designed to simultaneously quantify S v O 2 in the SSS and average blood flow velocity in internal carotid and vertebral arteries with four interleaves of RF-spoiled gradient-recalled echoes alternating between the two anatomic locations. To increase the temporal resolution of CMRO 2 quantification, the OxFlow sequence was modified to three interleaves with a different acquisition order ( Figure 1A ). The order of interleaves and corresponding slice locations are shown in Figures 1A and 1B . Henceforth, the modified sequence will be referred to as fast OxFlow or F-OxFlow. Pulse sequences were coded in SequenceTree, an open-source integrated software environment, and exported to MRI scanner with a custom-designed export module. 30 All but the second interleave were flow compensated. The first and second interleaves were acquired above the carotid bifurcation to quantify CBF by computing the phase difference image ( Figure 1C ). In the first interleave, the first gradient moment (m 1 ) of the slice-selection gradient (G z ) is nulled whereas in the second interleave the third lobe of G z is shifted to yield m 1 40. The third interleave acquires three echoes at the level of the SSS. However, the phase difference was computed between the equalpolarity echoes to quantify SSS S v O 2 . The second RF excitation pulse is applied at the level of the neck 12 ms after the first RF excitation, the third at the level of the SSS 12 ms after the second RF excitation pulse. The scheme of Figure 1A is repeated again 16 ms later. In this manner, spins at the level of the neck are excited with effective repetition times (TRs) of 12 and 28 ms, while at the level of the SSS TR = 40 ms. Experiments were conducted with the following scan parameters: FOV = 208 × 208 mm 2 , slice thickness = 5 mm, matrix size = 208 × 208. Scan parameters for the first and The difference in the TR between interleave one and two is a potential cause of signal modulation from the inflow effect, which could lead to a systematic error in CBF quantification. Another source of error results from the slight difference in the T 1 steady-state characteristics between the acquired signals used for CBF quantifications at interleaves one and two. However, the error associated with the variations in the T 1 steady-state characteristics is negligible given the average longitudinal relaxation time of the arterial blood (1,700 ms), 31 which is two orders of magnitude longer than difference in TR between interleaves one and two.
The potential ramifications of these problems were investigated in four healthy subjects by using a three-interleave phase-contrast sequence. The first and third interleaves were flow encoded (VENC = 60 cm/s) while the second interleave was flow compensated. Velocity maps were obtained from interleaves one and two, and two and three. To investigate potential bias caused by computing velocity maps with different degrees of T 1 steady-state mismatch, a range of TR values were chosen for the third interleave (TR 3 = 12, 16, 25, and 40 ms), while TR = 12 ms was used for first and second interleaves.
Image Processing and Analysis
For S v O 2 quantification, a phase difference image ( Figure 1D ) was computed from echoes 1 and 3 in the third interleave as
where Z 1 and Z 3 are the complex pixel values of the two echoes and the asterisk indicates the complex conjugate; γ is the proton gyromagnetic ratio.
The static background field inhomogeneity is characterized by a low spatial-frequency modulation across the FOV so its effects can be approximated and reduced with a second-order polynomial. 32 After subtracting the polynomial fit from the raw phase difference image Δϕ map , the phase difference (Δϕ) between intravascular blood and surrounding tissue was computed to quantify S v O 2 as:
For CBF quantification, a phase difference image ( Figure 1C) was computed from the first and second interleaves.
Magnetic Resonance Imaging Experiments
All imaging was performed at 3T on a Siemens Tim Trio system (Siemens Medical Solutions, Erlangen, Germany) with a 12-channel head and neck coil combination. Human subject studies were approved by the Institutional Review Board of the University of Pennsylvania. Analysis of patient data was performed in accordance with the Declaration of Helsinki.
Written consent was obtained from all subjects. Ten healthy human subjects (mean age = 33 ± 6 years, two females and eight males) participated in the study of baseline CMRO 2 , which consisted of measurement of SSS S v O 2 and CBF at the level of the neck using 8second and 30-second temporal resolution OxFlow sequences in the same session with five successive measurements being made for each method. Hct was measured for each subject via a capillary blood sample obtained from the fingertip (Hb 201+, Hemocue, Angelholm, Sweden). The angiogram of the head and neck vessels was generated with a 2D time-of-flight sequence to determine the proper location of the axial plane transecting the SSS at approximately right angle, as well as the slice distal to the carotid bifurcation, and the tilt angle of the SSS with respect to B o . 15 The location of both slices is indicated in the maximum intensity projection sagittal image ( Figure 1B) . Further, to calculate CMRO 2 per 100 gram of brain mass, a T 1 -weighted 3D MPRAGE (magnetization-prepared rapid gradient-echo) image of 1 mm isotropic spatial resolution was acquired to estimate brain volume for each subject. A brain density of 1.05 g/mL was used to calculate the brain mass. 33 
Quantification of Cerebral Metabolic Rate of Oxygen in Response to An Apneic Challenge
The apneic paradigm involved three repeated blocks of 32-second normal breathing baseline, 32-second breath hold apnea, and 88-second normal breathing recovery period. The time-course data of the apneic paradigm were averaged over the three repeated blocks to improve SNR. The subjects performed breath-hold at normal end expiration after being instructed to breathe in and breathe out. Arterial oxygen saturation (S a O 2 ) was continuously measured during the apneic paradigm using a digital pulse oximeter.
To exclude artifacts from inspiration and expiration during the last 6 seconds of the baseline period, 23 the first three data points in the timecourse data of the apneic paradigm were averaged to quantify baseline oximetric parameters value of S v O 2 , S a O 2 , and CBF, from which CMRO 2 was derived. The average CMRO 2 in response to the breath-hold challenge was quantified using the last two data points of the breath-hold challenge and the first point in the recovery period from the time-course data for each subject. In this manner, errors from residual signal modulations during successive inspiration and expiration before the start of the breath-hold period are minimized. 23 The temporal delay in the measured S a O 2 using the pulse oximeter was corrected by shifting backward in time the measured S a O 2 curve for each subject such that the oxygen resaturation in the arterial blood takes place approximately 8 seconds after the end of the breath-hold period. 23 This corresponds to the circulatory transport delay time between the lungs and brain. 34 Table 1 . CBF (mL/100 g/min) quantified from pairs of velocity-encoded images (referred to as CBF1 and CBF2) and the relative difference between them for a range of TR values for the third interleave in four subjects obtained with the three-interleave phase-contrast sequence Figure 1B shows an example of a sagittal localizer venogram indicating the location of S v O 2 and CBF measurements. Representative phase difference images at two anatomic locations for velocity and S v O 2 quantification are shown in Figures 1C and 1D , respectively.
RESULTS
The CBF values (i.e., CBF1 and CBF2) from both velocity maps quantified for four subjects using the three-interleave phase contrast sequence are listed in Table 1 . The average fractional differences between CBF1 and CBF2 for TR 3 ranging from 12 to 40 ms were 1.03%, 1.05%, 2.4%, and 2.5 %, i.e., the bias resulting from unequal TR is negligible.
Baseline S v O 2 , CBF, and CMRO 2 values quantified with OxFlow and F-OxFlow are listed in Table 2 . Average S v O 2 , CBF, and CMRO 2 values across all 10 subjects for F-OxFlow and OxFlow were 67.1 ± 3.4% and 66.3 ± 3.8% (P = 0.18, paired two-tailed t-test), 46.1 ± 5.6 and 45.1 ± 5.9 mL/100 g/min (P = 0.08, paired two-tailed t-test), and 123 ± 14 and 124 ± 12 (μmol/100 g/min) (P = 0.56, paired two-tailed t-test). These values are in good agreement with those reported recently in similar cohorts of young subjects. 15, 18 Further, a recent study by some of the authors of the current paper showed excellent agreement between susceptometry-based oximetry and TRUST in quantifying venous oxygenation (S v O 2 ). 35 It thus seems appropriate to compare F-OxFlow with its parent version. Figures 2A to 2C show correlations of the quantified parameters between the data obtained with the two methods. All three functional parameters were strongly correlated among the two sequences: S v O 2 (R 2 = 0.76, P o 0.001), CBF (R 2 = 0.92, P o 0.0001), and CMRO 2 (R 2 = 0.96, P o 0.0001).
The sensitivity of the sequence in capturing changes in the oximetric parameters in response to a breath-hold challenge is illustrated in Figure 3 , which represents the group-averaged timecourse plots over five subjects of the measured parameters S v O 2 , S a O 2 , CBF, and CMRO 2 . The data show the expected increases in CBF and S v O 2 along with a slight reduction in S a O 2 . Average increases in S v O 2, CBF, and CMRO 2 were 10.1 ± 2.5% (P = 0.0008, two-tailed t-test), 43.2 ± 9.2% (P = 0.0005, two-tailed t-test), and 7.1 ± 2.2% (P = 0.002, two-tailed t-test), respectively, while the average decrease in S a O 2 was − 3.4 ± 0.9% (P = 0.0011, two-tailed ttest). The average baseline values, average maximum values, and average change (i.e., increase or decrease) in S v O 2 , S a O 2 , CBF, and CMRO 2 for the five subjects evaluated are listed in Table 3 .
DISCUSSION
An MRI-based method denoted OxFlow has recently been reported for quantifying whole-brain CMRO 2 in 30 seconds scan time. 15 Although adequate for assessing baseline CMRO 2 and in response to hypercapnia, 18 the metabolic response to the stimulus often takes place on a shorter time-scale.
Here, we designed and implemented a substantially faster version of the parent OxFlow pulse sequence 15 that allows for simultaneous quantification of SSS S v O 2 and CBF in 8 seconds. The shortened scan time makes the technique potentially suited for monitoring dynamic changes. Comparison of the performance of the two sequences yielded strong correlations for S v O 2 (R 2 = 0.76, P o0.001), CBF (R 2 = 0.92, P o0.0001), and CMRO 2 (R 2 = 0.96, P o0.0001) ( Figure 2) . Further, the data indicate excellent agreement between both sequences with mean absolute differences of 2.2%, 3.4%, and 2.0% for S v O 2 , CBF, and CMRO 2 , respectively, none of the means being significantly different from each other (P = 0.18, P = 0.08, and P = 0.56 for S v O 2 , CBF, and CMRO 2 , respectively). Each measurement was repeated five times consecutively in each session resulting in an average SD in the quantified S v O 2 , CBF, and CMRO 2 of 2.0%, 2.8%, and 6.4%, respectively ( Table 2 ). The data suggest that at baseline the quantified S v O 2 , CBF, and CMRO 2 to be stable physiologic parameters.
The data in Figure 3 suggest that F-OxFlow is able to monitor the hemodynamic and metabolic changes occurring during an apnea paradigm. Although Doppler ultrasound 36 and nearinfrared spectroscopy 37 have provided insight into the physiologic response to apneic events in subjects with obstructive sleep apnea, the latter two techniques detect the relative dynamic changes in either CBF or cerebral tissue oxygenation, rather than CMRO 2 in absolute physiologic units. Our results are in good quantitative agreement with those reported for a nearly identical paradigm using a rapid MRI-based technique in which both CBF and S v O 2 were measured in the SSS. 23 The observed increase in CMRO 2 likely arises because breath-hold (i.e., volitional apnea) is a mixed hypercapnic/hypoxic stimulus. In a previous study by some of the authors of the present paper based on a similar susceptometric approach showed that hypercapnia is isometabolic. 18 However, T 2 -based oximetry (i.e., TRUST) showed 5 ± 2% increase of CMRO 2 in response to mild hypoxia. 10 Therefore, the increase in CMRO 2 in response to volitional apnea is plausible, if seen as a combination of isometabolic (hypercapnia) and pro-metabolic (hypoxia) stimuli, as observed in recent work by Rodgers et al. 23 Table 2 . Oximetric parameters (means ± s.d.) at baseline: S v O 2 (%), CBF (mL/100 g/min), CMRO 2 (μmol/100 g/min) for 10 subjects obtained with
F-OxFlow and OxFlow
To achieve accurate nontriggered PC velocity quantification, it is necessary to minimize the inflow-related blood signal modulation between successive pulse cycles due to variation in blood-flow velocity during the cardiac cycle. 38 Of course, as long as TR is long enough for complete spin replacement between successive excitations, no amplitude modulation can occur. This is easily achieved in OxFlow where the slice thickness and effective TR are 5 mm and 70 ms, respectively, i.e., blood water protons will be refreshed for average blood flow velocity as low as 7.2 cm/s. However, in F-OxFlow the duration of the pulse sequence cycle at the level of the flow measurement is much shorter, alternating between 12 and 28 ms. Nevertheless, our data comparing F-OxFlow to the parent pulse sequence (Table 1) indicate nonsignificant bias in the extracted data. These findings are in accordance with results by Bakker et al, 38 who showed that for monophasic flow waveforms (such as carotid and vertebral arteries) signal modulation for small flip angles ⩽ 15°is negligible as a source of error in nontriggered phase-contrast velocity measurements.
In recent work by some of the present authors, a three-second temporal resolution sequence was reported for quantification of CMRO 2 by measuring both S v O 2 and CBF at the SSS (SSS-BF) instead of in the neck arteries. 23 This sequence, although faster by a factor of 2.5, requires running a 12-second phase-contrast reference scan with two-slice interleaves alternated between the SSS and neck arteries at baseline. The reference sequence is required to estimate tCBF from the SSS-BF:CBF ratio at baseline. In , cerebral blood flow (CBF) (mL/100 g/min), and cerebral metabolic rate of oxygen (CMRO 2 ) (μmol/100 g/min) over five subjects during an apneic paradigm. The shaded area represents the volitional apnea period. Average values of the oximetric parameters at baseline were calculated from the first three data points (black-filled squares corresponding to the bracketed section 'Baseline') from the timecourse data for each subject. The average CMRO 2 in response to volitional apnea is calculated from the three CMRO 2 data points (red-filled squares corresponding to the bracketed section 'End-Apnea') from the time-course data for each subject. Maximum S v O 2 and CBF and the minimum S a O 2 values were calculated using data points denoted by the yellow-filled squares from the average timecourse data of the five subjects. Abbreviations: CBF, cerebral blood flow; CMRO 2 , cerebral metabolic rate of oxygen.
Fast MRI quantification of CMRO 2 S Barhoum et al dynamic applications such as the study of the response to breathhold, it is assumed that SSS-BF:CBF ratio remains constant during the paradigm. This ratio was shown to remain constant for healthy subjects in response to a mixed hypercapnic-hypoxic paradigm. 23 However, it is conceivable that this ratio could vary during physiologic challenges in certain disease populations, for example, those with disorders affecting venous hemodynamics. Recently, a simplified version of the OxFlow technique in which, similarly, both S v O 2 and tCBF were measured in the SSS, has been applied in a translational study in neonates. 39 However, rather than measuring the SSS-BF:CBF ratio it was assumed to be 50%. One potential problem of all methods designed to quantify temporal changes in AVO 2 (such as induced apnea) is pulse oximetry used for measuring S a O 2 . Errors resulting from poor perfusion at the measurement site (e.g. finger) may provide false readings. 40 In principle, S a O 2 can be quantified in the internal carotids and vertebral arteries using MR susceptometry. However, the presence of the trachea and air spaces in the neck cause severe static field inhomogeneities, making it difficult to measure S a O 2 in the neck arteries. Further, it is challenging to detect small desaturation effects since the phase difference of the signal with respect to tissue is small. This is an area of future investigation, especially with the better background field removal methods that now exist. Finally, all image reconstruction and analysis is currently performed offline from the raw k-space data. The logical next step will be to more tightly integrate the processing into the scanner's pipeline and operator console to facilitate its use in a clinical setting.
In conclusion, we have introduced an accelerated version of an MRI-based method that allows estimation of global brain CMRO 2 at 8-second temporal resolution by simultaneously quantifying CBF and S v O 2 . The method may be suited for monitoring the response to nonsteady-state stimuli such as apnea.
